Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins.

Niwa M, Noda K, Kobayashi Y, Kageyama I, Kodama K

Open source

DOI
10.1080/17576180.2025.2515011
Published
2025 May
Container
Bioanalysis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17576180.2025.2515011,
  title = {Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins.},
  author = {Niwa M and Noda K and Kobayashi Y and Kageyama I and Kodama K},
  year = {2025},
  journal = {Bioanalysis},
  doi = {10.1080/17576180.2025.2515011},
  url = {https://doi.org/10.1080/17576180.2025.2515011}
}

RIS

TY  - JOUR
TI  - Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins.
AU  - Niwa M
AU  - Noda K
AU  - Kobayashi Y
AU  - Kageyama I
AU  - Kodama K
PY  - 2025
JO  - Bioanalysis
DO  - 10.1080/17576180.2025.2515011
UR  - https://doi.org/10.1080/17576180.2025.2515011
ER  - 

APA

M, N., K, N., Y, K., I, K., & K, K. (2025). Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins.. Bioanalysis. https://doi.org/10.1080/17576180.2025.2515011

Source records